Netherlands· NL-40cacdc26fc7
Teglutik 5 mg/ml, suspensie voor oraal gebruik
A riluzole product containing riluzol, registered in Netherlands by Italfarmaco, S.A.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Riluzole is registered in 17 of 19 countries.
Countries holding a registration under ATC N07XX02 (riluzole), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Riluzole · ATC N07XX02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of riluzole costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $5.62 in France to $9.14 in Italy — a ×1.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Riluzole · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- IT Italy$9.14
- CH Switzerland$8.63
- FR France$5.62
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RILUZOL
- Manufacturer
- Italfarmaco, S.A.
- Country
- Netherlands (NL)
- ATC code
- N07XX02
- ATC class
- Riluzole
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id128121
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
46 interactions on record for riluzole.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Riluzole · interactions on record
46 records
- 4 severe
- 28 moderate
- 5 minor
- 9 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Riluzole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTeglutik 5 mg/mlItalfarmaco
- SwitzerlandTeglutik 50mg/10ml, suspension buvableEFFIK SA
- SpainTEGLUTIK 5MG/ML SUSPENSION ORALItalfarmaco S.A.
- FinlandTeglutikItalfarmaco SA
- FranceTEGLUTIK 5 mg/ml, suspension buvableITALFARMACO (ESPAGNE)
- NorwayTeglutikItalfarmaco S.A.
- SwedenTeglutik 5 mg/ml Oral suspensionItalfarmaco S.A.
- United StatesTIGLUTIKItalfarmaco SPA
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emylif, Riluzol Aristo
- Belgium · Emylif, Riluzol Ab
- Cyprus · Teglutik
- Czechia · Riluzol Pmcs
- Germany · Emylif, Glentek
- Denmark · Emylif, Glentek
- Estonia · Lizolorol, Rilustad
- Spain · Emylif, Riluzol Aurovitas
- Finland · Teglutik
- France · Emylif, Riluzole Arrow
- United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
- Greece · Teglutik
- Croatia · Alsemol
- Hungary · Sclefic
- Iceland · Emylif, Rilutek
- Italy · Emylif, Riluzolo Aurobindo
- Liechtenstein · Rilutek, Riluzole Zentiva
- Luxembourg · Emylif, Teglutik
- Norway · Emylif, Rilutek
- Poland · Riluzol Pmcs, Riluzole Sun
- Portugal · Emylif, Riluzol Aurovitas
- Romania · Riluzol Pmcs
- Sweden · Emylif, Glentek
- Slovenia · Sclefic
- Slovakia · Riluzol Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa9af2fa-cd47-42bf-913c-d95f005b1792 GET /v1/drugs/fa9af2fa-cd47-42bf-913c-d95f005b1792?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor oraal gebruik, Suspensie voor gastro-enteraal gebruik",
"route": "Oraal gebruik, Gastro-enteraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128121_smpc.pdf",
"strength": null,
"atc_label": "Riluzole",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128121",
"excipients": [
"ALUMINIUMMAGNESIUMSILICAAT",
"BENZOËZUUR (E 210)",
"DIMETICON (E 900)",
"MACROGOLCETOSTEARYLETHER",
"NATRIUMLAURILSULFAAT",
"SACCHAROIDE NATRIUM X-WATER (E 954)",
"SILICIUMDIOXIDE (E 551)",
"SIMETICON EMULSIE",
"SORBINEZUUR (E 200)",
"SORBITOL, VLOEIBAAR, NIET-KRISTALLISEERBAAR (E 420)",
"WATER, GEZUIVERD",
"XANTHAANGOM (E 415)"
],
"substances": [
"RILUZOL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128121.pdf",
"authorised_at": "2022/04/21",
"procedure_number": "IT/H/0308/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "128121",
"additional_monitoring": "N"
}See everything about riluzole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.